Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.
Reposted from 22nd March - History Repeating .... this time with better news ....
Compare Nov 22 when the last decent flag pole started forming, flag stretched out to Jan 2023. ( bagged from 2.23p to 4.3p )
Then continued in a classic 5 stage leg up to 8.5p.
We are back at the 2.23 point but there is no risk of dividends to detract from the drill programme and they have loaded loads more news in, more drills, boat has a conformed contract, block 8, South Yelemes are producing more oil on horizontal drills etc etc.
Last time it went from 2.23p to 8.5p in 5 months and all you had to do was hold for nearly 300%... only reason it stopped going higher was their insistence on taking Divi money and putting it into the UAE coffers, thereby cutting off the drill and workover ratio.
With Block 8 coming onboard they won't do that again.
Still moored.
Weirdly the Meliana - a Chemical tanker is still docked alongside, hasn't moved for weeks.
Every other ship in that small port has dropped off cargo/taken on fresh loads and moved on...
Mike,
Then split out the home and away they have to sell some to the home market.
They could hit this just on South Yelemes, or 155, or smash it with A5, A6,A7,801,802 or 803.
Last year on less news it did 2.4p to 8.5p.
I'd start there?
Still think that's too cheap for what they've outlined is coming.
Not interested in 5p ... chump change!
Sitting and waiting, selling oilfields, licensing a deep, redrilling A5, buying block 8, renting the drill barge, first time in years ...
Multiples of 5p...
The great thing with AIM BOD's is they can chat to each other and agree the options we're probably set too high.
Especially after issuing 5hit loads of shares for placings ...
Then they can agree they will lower their options...
I'm still invested here Dibs, just telling it like it is on AIM ;)
They'll get India sorted by then.
India is being pilot scheme funded in charitable donations, they will then ask for central Government support / funding to cover the whole country.
Months away at the earliest, same as UK NHS.
Unless it can bring cash in via licensing bleepa to usa? I'd expect another £5m? Raise to keep all these trials running, unless Tom can man up and sell the proposition instead of giving it away.
Was reading about bids this morning, old favourite, great product, 5hit BOD, was obvious a while ago, come on Tom cup those balls in one hand and go sell some Bleepa!
That's decent, realistic, factual.
No b.s. in there, good snapshot of the business.
Note they are stockpiling and not just selling.
They'll prolly be doing that by May
Mike
To sell 70k a month on inter licence is only circa 3k bopd
U mean 3.27?
Earl - you pick up some casp - its moving again.
Davey, I disagree with that I think the pumpers and dumpers can alert you to some good stocks you wouldn't otherwise know about, wait for them to leave then buy in on the retrace and wait.
So take out $100m for FDP and its circa 9 cents then.
Take out $100m for the field development plan, divide remiaing $200m by 2.1b shares
Good point re: Galaxy
So if $300m
Take $100 towards field development plan.
$200m dividend of which Kuat gets half and we get 9 cents gross?
So fully developed deeps and a divi?
AIM isn't the worry.
You can do what you want.
Your issues are kazakhstans sub soil users agreement.
Need each oil field on separate, clearly identifiable licences.
Delineated by topographical size and then depth.
Example 3ab vs Dunga where Dunga owns the oil down to 2500m and thereafter 3ab own it.
Jup4it ...
Lets say that Kuat instigated the dividend to put his 50% into his UAE Bank Accounts.
If he sells the shallows for $100m pays 10% tax and takes his 50% as a divi to the UAE that gives a 60 year old nan $45m.
That covers a heck of a lot of green fees doesn't it?
If 801,802 and 803care pumping the Co won't even miss it ...
Pretomanid is used on drug resistant TB strains, sold by Viatris, now promoted into India via the Heal foundation and Bleepa and Carelocker.
https://en.wikipedia.org/wiki/Pretomanid
Europe https://www.ema.europa.eu/en/medicines/human/EPAR/dovprela-previously-pretomanid-fgk
U.S.A. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9461242/
India https://www.viatris.com/en-in/lm/India ( https://www.mylan.in/en/news/press-releases/2020/mylan-secures-dcgi-approval-in-india-for-pretomanid-a-treatment-for-highly-drug-resistant-forms-of-tuberculosis )
According to the report, India accounted for the highest global TB burden, with 27% of the 10.6 million people diagnosed with the disease in 2022. The country is also home to 47% of people who developed multi-drug resistant infection which is unresponsive or resistant to at least two of the first line of anti-TB drugs the same year.
Bleepa get paid to test everyone as they have to have a carelocker file set up, Viatris get to sell the cure to those affected.
This is take off time.
#FDBK
WHY are Viatris paying for Heal and Bleepa to test all of Indias 1.4B people?
Pretomanid
Viatris has launched pretomanid, specifically approved for adults with MDR-TB. It’s only the third new anti-TB drug approved in the past half-century.
THEY OWN THE CURE!
I read the RNS and had a head scratch about a charity funding this with donations for the whole of India, had a google search.
Heal is a charity, it is run by a Pharmaceutical giant called Viatris, tied in with the Indian Government to eradicate TB by 2025.
To do this they need fast, snappy communications from medical people to the Indian population to tell them clear or infected, they have an obvious weakness in communications and this is the area that Bleepa and care locker fill.
Viatris filed this ...
FY 2023 results:
‣ Total Revenues $15.4B
‣ Adjusted EBITDA $5.1B
‣ Free Cash Flow $2.4B
https://investor.viatris.com/static-files/4ba5a0bf-5ae4-4425-a697-233a95c6c763
Dr Dhara Shah, Head of Medical Affairs, Viatris India, said, “TB eradication in India is at a crucial juncture. The government is spearheading the TB elimination program to end TB by 2025. Via the India Fights TB initiative, we will provide accurate information to patients,
revenue growth
‣ FY 2023 results:
‣ Total Revenues $15.4B
‣ Adjusted EBITDA $5.1B
‣ Free Cash Flow $2.4B
https://investor.viatris.com/financial-and-filings/quarterly-results
Feeling more relaxed now a "charity" is going to support Bleepa in India.
Why is it still under a tenner?